跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
RIVAROXABAN ALMUS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
RIVAROXABAN ALMUS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Almus Farmaceutica S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 25, 2022
Approval ID
ca0ca4d289c9b5e0
Company
Almus Farmaceutica S.A.U.
Type
Standard
Approval Details
Approval Id
ca0ca4d289c9b5e0
Drug Cima Aemps Name
RIVAROXABAN ALMUS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88051
Holder Company Name
Almus Farmaceutica S.A.U.
Marketing Company Name
Almus Farmaceutica S.A.U.
Authorization Date
2022-08-25
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Almus Farmaceutica S.A.U.
Active Ingredients
RIVAROXABAN
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 25, 2022
Approval ID
ca0ca4d289c9b5e0
Type
Standard
Back to CIMA-AEMPS Approvals
RIVAROXABAN ALMUS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details